Clinical Trial Update: Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the safety and efficacy of bivalirudin in reducing bleeding risk during left atrial appendage occlusion across multiple centers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Atrial Appendage Occlusion

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Evaluate the Safety and Efficacy of Bivalirudin in Decreasing Bleeding Risk | Phase 4 | Status: UNKNOWN